Evidence map›Paper›PMID 30245926›Full record

ArticlePeerJ2018

Exome sequencing study of 20 patients with high myopia.

Ling Wan, Boling Deng, Zhengzheng Wu, Xiaoming Chen

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ling WanDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Boling DengDepartment of Ophthalmology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital and Affiliated Hospital of University of Electronic Science and Technology, Chengdu, Sichuan, China.
Zhengzheng WuDepartment of Ophthalmology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital and Affiliated Hospital of University of Electronic Science and Technology, Chengdu, Sichuan, China.
Xiaoming ChenDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh myopia is a common ocular disease worldwide. To expand our current understanding of the genetic basis of high myopia, we carried out a whole exome sequencing (WES) study to identify potential causal gene mutations.

methodsA total of 20 individuals with high myopia were exome sequenced. A novel filtering strategy combining phenotypes and functional impact of variants was applied to identify candidate genes by multi-step bioinformatics analyses. Network and enrichment analysis were employed to examine the biological pathways involved in the candidate genes.

resultsIn 16 out of 20 patients, we identified 20 potential pathogenic gene variants for high myopia. A total of 18 variants were located in myopia-associated chromosomal regions. In addition to the novel mutations found in five known myopia genes ( DISCUSSION: Systematic mutation analysis of candidate genes was performed using WES data, functional interaction (FI) network, Gene Ontology and pathway enrichment. FI network analysis revealed important network modules and regulator linker genes (

Indexed as

BioinformaticsGenomicsGO and FI network enrichmentHigh myopiaPathway enrichmentQTLWhole exome sequencing

Identifiers

PMID30245926
PMCPMC6148412
OpenAlexW2890051770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.